194 related articles for article (PubMed ID: 36610489)
21. The presence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor on patients with rheumatoid arthritis (RA) does not interfere with the chance of clinical remission in a follow-up of 3 years.
da Mota LM; Dos Santos Neto LL; de Carvalho JF; Pereira IA; Burlingame R; Ménard HA; Laurindo IM
Rheumatol Int; 2012 Dec; 32(12):3807-12. PubMed ID: 22187055
[TBL] [Abstract][Full Text] [Related]
22. Clinical diagnostic significance of 14-3-3η protein, high-mobility group box-1, anti-cyclic citrullinated peptide antibodies, anti-mutated citrullinated vimentin antibodies and rheumatoid factor in rheumatoid arthritis.
Huang J; Zeng T; Zhang X; Tian Y; Wu Y; Yu J; Pei Z; Liu Y; Hu T; Tan L
Br J Biomed Sci; 2020 Jan; 77(1):19-23. PubMed ID: 31433746
[No Abstract] [Full Text] [Related]
23. Greater prevalence of seropositivity for anti-cyclic citrullinated peptide antibody in unaffected first-degree relatives in multicase rheumatoid arthritis-affected families.
Kim SK; Bae J; Lee H; Kim JH; Park SH; Choe JY
Korean J Intern Med; 2013 Jan; 28(1):45-53. PubMed ID: 23345996
[TBL] [Abstract][Full Text] [Related]
24. Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity.
Shakiba Y; Koopah S; Jamshidi AR; Amirzargar AA; Massoud A; Kiani A; Nicknam MH; Nazari B; Nikbin B
Iran J Allergy Asthma Immunol; 2014 Jun; 13(3):147-56. PubMed ID: 24659118
[TBL] [Abstract][Full Text] [Related]
25. Disordered Antigens and Epitope Overlap Between Anti-Citrullinated Protein Antibodies and Rheumatoid Factor in Rheumatoid Arthritis.
Zheng Z; Mergaert AM; Fahmy LM; Bawadekar M; Holmes CL; Ong IM; Bridges AJ; Newton MA; Shelef MA
Arthritis Rheumatol; 2020 Feb; 72(2):262-272. PubMed ID: 31397047
[TBL] [Abstract][Full Text] [Related]
26. Impact of Cyclic Citrullinated Peptide Antibody Level on Progression to Rheumatoid Arthritis in Clinically Tested Cyclic Citrullinated Peptide Antibody-Positive Patients Without Rheumatoid Arthritis.
Ford JA; Liu X; Marshall AA; Zaccardelli A; Prado MG; Wiyarand C; Lu B; Karlson EW; Schur PH; Deane KD; Sparks JA
Arthritis Care Res (Hoboken); 2019 Dec; 71(12):1583-1592. PubMed ID: 30570827
[TBL] [Abstract][Full Text] [Related]
27. Relatives without rheumatoid arthritis show reactivity to anti-citrullinated protein/peptide antibodies that are associated with arthritis-related traits: studies of the etiology of rheumatoid arthritis.
Young KA; Deane KD; Derber LA; Hughes-Austin JM; Wagner CA; Sokolove J; Weisman MH; Buckner JH; Mikuls TR; O'Dell JR; Keating RM; Gregersen PK; Robinson WH; Holers VM; Norris JM
Arthritis Rheum; 2013 Aug; 65(8):1995-2004. PubMed ID: 23754702
[TBL] [Abstract][Full Text] [Related]
28. Predictive value of antibodies to cyclic citrullinated peptide in patients with early arthritis.
Ateş A; Karaaslan Y; Aksaray S
Clin Rheumatol; 2007 Apr; 26(4):499-504. PubMed ID: 16670828
[TBL] [Abstract][Full Text] [Related]
29. Anticyclic Citrullinated Peptide Antibodies and Rheumatoid Factor as Risk Factors for 10-year Cardiovascular Morbidity in Patients with Rheumatoid Arthritis: A Large Inception Cohort Study.
Berendsen MLT; van Maaren MC; Arts EEA; den Broeder AA; Popa CD; Fransen J
J Rheumatol; 2017 Sep; 44(9):1325-1330. PubMed ID: 28668802
[TBL] [Abstract][Full Text] [Related]
30.
Guzmán-Guzmán IP; Ramírez-Vélez CI; Falfán-Valencia R; Navarro-Zarza JE; Gutiérrez-Pérez IA; Zaragoza-García O; Ramírez M; Castro-Alarcón N; Parra-Rojas I
Front Immunol; 2021; 12():718246. PubMed ID: 34421923
[TBL] [Abstract][Full Text] [Related]
31. Enhanced neutrophil phagocytic capacity in rheumatoid arthritis related to the autoantibodies rheumatoid factor and anti-cyclic citrullinated peptides.
de Siqueira MB; da Mota LM; Couto SC; Muniz-Junqueira MI
BMC Musculoskelet Disord; 2015 Jun; 16():159. PubMed ID: 26123215
[TBL] [Abstract][Full Text] [Related]
32. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
33. A Retrospective Study: The Significance of Combined Testing of Serum Markers for Diagnosis of Rheumatoid Arthritis.
Mu F; Wu H; Wang Y
Med Sci Monit Basic Res; 2017 Aug; 23():295-303. PubMed ID: 28855496
[TBL] [Abstract][Full Text] [Related]
34. Autoantibodies in prediction of the development of rheumatoid arthritis among healthy relatives of patients with the disease.
Ramos-Remus C; Castillo-Ortiz JD; Aguilar-Lozano L; Padilla-Ibarra J; Sandoval-Castro C; Vargas-Serafin CO; de la Mora-Molina H; Ramos-Gomez A; Sanchez-Ortiz A; Avila-Armengol H; Aceves-Avila FJ
Arthritis Rheumatol; 2015 Nov; 67(11):2837-44. PubMed ID: 26245885
[TBL] [Abstract][Full Text] [Related]
35. Circulating anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis and chronic obstructive pulmonary disease.
Yang DH; Tu CC; Wang SC; Wei CC; Cheng YW
Rheumatol Int; 2014 Jul; 34(7):971-7. PubMed ID: 24366391
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the diagnostic potential of three anti-citrullinated protein antibodies as adjuncts to rheumatoid factor and CCP in a cohort of South African rheumatoid arthritis patients.
Meyer PWA; Ally MTM; Hodkinson B; Anderson R; Tikly M
Rheumatol Int; 2018 Jun; 38(6):993-1001. PubMed ID: 29713794
[TBL] [Abstract][Full Text] [Related]
37. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Greiner A; Plischke H; Kellner H; Gruber R
Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
[TBL] [Abstract][Full Text] [Related]
38. The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis.
Shovman O; Gilburd B; Zandman-Goddard G; Sherer Y; Orbach H; Gerli R; Shoenfeld Y
Clin Dev Immunol; 2005 Sep; 12(3):197-202. PubMed ID: 16295525
[TBL] [Abstract][Full Text] [Related]
39. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
Us D; Gülmez D; Hasçelik G
Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
[TBL] [Abstract][Full Text] [Related]
40. Associations of HLA-DRB1 alleles with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in northern east part of Turkey.
Uçar F; Çapkin E; Karkucak M; Yücel B; Sönmez M; Alver A; Kaklikkaya N; Tosun M; Alemdaroğlu E; Solak M
Int J Rheum Dis; 2012 Dec; 15(6):538-45. PubMed ID: 23253237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
